Literature DB >> 27935598

The gene polymorphisms of IL-8(-251T/A) and IP-10(-1596C/T) are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population.

L Dong1, J Bai1, X Jiang1, M-M Yang1, Y Zheng1, H Zhang1, D Lin2.   

Abstract

PurposeThe aim of the present study is to investigate the association of the polymorphism of two genes in CXC chemokine family, interleukin-8 (IL-8) and interferon-inducible protein 10 (IP-10), with both susceptibility and progression of DR in T2D population of northern China.Patients and methodsA total of 1043 eligible type 2 diabetic patients from Heilongjiang of northern China were recruited for this study. They were grouped into: with diabetic retinopathy (DR, 528 cases) and without diabetic retinopathy (DNR, 515 cases). Single nucleotide polymorphism (SNP) genotyping of IL-8(-251T/A) and IP-10(-1596C/T) was performed by polymerase chain reaction. Multivariate analysis and stepwise multiple logistic progression analysis were conducted to evaluate the association between gene SNP and DR susceptibility and progression. Pooled odds ratio (OR) with 95% confidence interval (CI) was applied to assess the strength of the association among study groups.ResultsThe occurring of IL-8(-251) AA genotype was correlated with susceptibility (OR: 2.286, 95% CI: 1.382-3.782, P=0.001) and progression of high-risk proliferative diabetic retinopathy (PDR) (OR: 0.354, 95% CI: 0.162-0.770, P=0.009). Reversely, T allele of IP-10 (-1596) C/T was correlated with a reduced risk of DR (OR: 0.341, 95% CI: 0.249-0.466, P<0.001). However, gene polymorphisms of IL-8-251T/A and IP-10-1596C/T were not associated with diabetic macular edema (DME)(P>0.05).ConclusionsAA genotype of IL-8-251T/A was closely correlated to DR and high-risk proliferative diabetic retinopathy (PDR). -1596T allele of the IP-10 is a beneficial genotype for DR.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27935598      PMCID: PMC5396005          DOI: 10.1038/eye.2016.287

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  41 in total

1.  Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells.

Authors:  Yue Wang; Jie Yang; Yan Gao; Yongrui Du; Leyuan Bao; Wenyan Niu; Zhi Yao
Journal:  Cell Mol Immunol       Date:  2005-10       Impact factor: 11.530

Review 2.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

Authors:  K Matsushima; J J Oppenheim
Journal:  Cytokine       Date:  1989-11       Impact factor: 3.861

3.  Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

Authors:  Wu Zhang; Jan Stoehlmacher; David J Park; Dongyun Yang; Erin Borchard; Ji Gil; Denice D Tsao-Wei; Jim Yun; Michael Gordon; Oliver A Press; Katrin Rhodes; Susan Groshen; Heinz-Josef Lenz
Journal:  Clin Colorectal Cancer       Date:  2005-07       Impact factor: 4.481

Review 4.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.

Authors:  Laura Boldrini; Silvia Gisfredi; Silvia Ursino; Marco Lucchi; Alfredo Mussi; Fulvio Basolo; Raffaele Pingitore; Gabriella Fontanini
Journal:  Lung Cancer       Date:  2005-08-24       Impact factor: 5.705

6.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.

Authors:  J Kyle Krady; Anirban Basu; Colleen M Allen; Yuping Xu; Kathryn F LaNoue; Thomas W Gardner; Steven W Levison
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells.

Authors:  V M Elner; R M Strieter; S G Elner; M Baggiolini; I Lindley; S L Kunkel
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

9.  Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells.

Authors:  Z M Bian; S G Elner; R M Strieter; M B Glass; N W Lukacs; S L Kunkel; V M Elner
Journal:  J Leukoc Biol       Date:  1996-09       Impact factor: 4.962

10.  Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis.

Authors:  R M Strieter; S L Kunkel; D A Arenberg; M D Burdick; P J Polverini
Journal:  Biochem Biophys Res Commun       Date:  1995-05-05       Impact factor: 3.575

View more
  4 in total

Review 1.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

2.  Dynamic networks of P300-related process.

Authors:  Qin Tao; Lin Jiang; Fali Li; Yuan Qiu; Chanlin Yi; Yajing Si; Cunbo Li; Tao Zhang; Dezhong Yao; Peng Xu
Journal:  Cogn Neurodyn       Date:  2022-01-10       Impact factor: 3.473

Review 3.  Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment.

Authors:  Rajya L Gurung; Liesel M FitzGerald; Bennet J McComish; Nitin Verma; Kathryn P Burdon
Journal:  J Diabetes Res       Date:  2020-11-12       Impact factor: 4.011

4.  IGF1 gene polymorphisms associated with diabetic retinopathy risk in Chinese Han population.

Authors:  Jian Zhang; Xiao Chen; Like Zhang; Yi Peng
Journal:  Oncotarget       Date:  2017-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.